Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Alimera SciencesRegeneRx BiopharmaceuticalsEvoke PharmaGenerex BiotechnologyAddex Therapeutics
SymbolNASDAQ:ALIMOTCMKTS:RGRXNASDAQ:EVOKOTCMKTS:GNBTOTCMKTS:ADDXF
Price Information
Current Price$3.68$0.18$1.12$0.51$1.70
52 Week RangeBuyN/AHoldN/AN/A
Analyst Ratings
Consensus RecommendationBuyN/AHoldN/AN/A
Consensus Price Target$30.00N/AN/AN/AN/A
% Upside from Price Target715.22% upsideN/AN/AN/AN/A
Trade Information
Market Cap$19.98 million$24.15 million$27.36 million$25.74 million$44.83 million
Beta1.850.182.04-4.320.55
Average Volume46,31390,764191,401708,959N/A
Sales & Book Value
Annual Revenue$53.94 million$80,000.00N/A$6.20 millionN/A
Price / Sales0.34301.91N/A4.15N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($7.01) per share($0.02) per share$0.18 per share$0.09 per shareN/A
Price / Book-0.52-9.05N/A5.67N/A
Profitability
Net Income$-10,440,000.00$-1,400,000.00$-7,130,000.00$-9,340,000.00N/A
EPS($2.19)N/A($0.32)N/AN/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E Ratio5.18N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-19.36%-1,844.05%N/AN/AN/A
Return on Equity (ROE)N/AN/A-150.20%-534.10%N/A
Return on Assets (ROA)-20.93%-151.91%-110.82%-57.05%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio2.72%2.82%3.10%0.05%N/A
Quick Ratio2.60%2.82%3.10%0.03%N/A
Ownership Information
Institutional Ownership Percentage30.37%0.18%6.02%N/AN/A
Insider Ownership Percentage14.60%10.90%13.16%35.20%N/A
Miscellaneous
Employees12436317
Shares Outstanding4.97 million133.44 million24.23 million50.46 million26.37 million
Next Earnings Date5/4/2020 (Estimated)4/3/2020 (Estimated)5/13/2020 (Estimated)N/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel